患者对多发性硬化和疾病修饰疗法的影响的经验
Bari Talente1, Lisbet T Finseth1, Natalie Blake2
1National Multiple Sclerosis Society, Washington, DC, USA.
ClinicoEconomics and outcomes research : CEOR
|March 20, 2025
概括
多发性硬化症患者面临巨大的情感和财务负担,影响治疗决策. 了解这些患者的经验是改善多发性硬化症护理和治疗坚持的关键.
科学领域:
- 神经学 神经学
- 医疗保健服务研究 医疗服务研究
背景情况:
- 疾病修饰疗法 (DMT) 对于多发性硬化症 (MS) 管理至关重要.
- 行政数据研究往往忽视了患者的偏好和临床决策因素.
- 患者经验数据对于优化多发性硬化症治疗的启动,坚持和结果至关重要.
研究的目的:
- 调查患者报告的与多发性硬化症相关的情感和财务负担.
- 确定影响治疗决策的关键因素以及MS患者中DMT的障碍.
- 收集有关改善多发性硬化护理和治疗策略的见解.
主要方法:
- 一项对1323名患有多发性硬化或临床隔离综合征的美国成年人进行的横截面在线调查.
- 由MS联盟从2022年12月到2023年1月收集的数据.
- 混合方法分析,包括后勤回归和主题分析.
主要成果:
- 参与者报告说,他们对独立 (80%),财务 (65%),情感健康 (64%),人际关系 (57%) 和职业生涯 (42%) 有很大的担忧.
- 关键的DMT启动因素包括减缓进展 (92%),预防复发 (89%) 和医生建议 (89%).
- 财务障碍 (例如,高成本,保险问题) 导致19%的患者延迟或停止治疗;50%的患者由于各种原因停止了DMT.
结论:
- 患有多发性硬化症的生活带来了巨大的情感和财务挑战,影响了独立和人际关系.
- 调查结果强调需要采用整体护理方法.
- 为管理护理,研究和医疗保健提供者提供可操作的建议,以满足患者的需求.
相关概念视频
Drug Therapy
32
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
32
Parkinson's Disease: Overview
405
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
405
Myasthenia Gravis: Overview and Treatment
1.1K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.1K
Modeling in Therapy
39
Modeling, a key technique in therapy, uses observational learning to help clients acquire and practice new skills by watching therapists demonstrate desired behaviors. This approach, rooted in Albert Bandura's concept of vicarious learning, plays a significant role in therapeutic interventions for various psychological conditions, including social anxiety, ADHD, and depression.
Participant Modeling
Participant modeling involves therapists demonstrating calm and effective behaviors in...
Participant Modeling
Participant modeling involves therapists demonstrating calm and effective behaviors in...
39
Autoimmune Disorders
366
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
Concept and Mechanism of Autoimmune Diseases
The immune...
366
Inflammatory Bowel Disease IV: Pharmacological Management
83
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
83


